About the journal
Drugs in Context is an open-access journal published by BioExcel Publishing Ltd in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,000 GBP. Declared review time at DOAJ: 9 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BioExcel Publishing Ltd
- ISSN
- 1745-1981 · 1740-4398
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,000 GBP
- Articles in DOAJ
- 566
- Declared review time
- 9 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.drugsincontext.com
Index listings
- DOAJ · 2013-05-30
- PUBMED · 2012-11-19
- Indexing
- DOAJ · PUBMED
- APC
- 2,000 GBP
- Declared review time (DOAJ)
- 9 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
566
Most recent article
last month
Average review time (journal-declared via DOAJ)
9weeks
Works in OpenAlex
617
Last recorded publication year
2026
h-index
52
i10-index
248
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2024-09-24
- Added to DOAJ
- 2013-05-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- Yes
- Declared digital preservation
- PMC
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 25%
- ORCID iDs in current deposits
- 4%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Journal of interventions in clinical practiceDrugs in context monograph
- Source type
- journal
- NLM unique ID (PubMed)
- 101262187
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Dermatology and Skin Diseases
- Dermatology and Skin Diseases
Show all subjects (50)
- Spondyloarthritis Studies and Treatments
- Spondyloarthritis Studies and Treatments
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Heart Failure Treatment and Management
- Rheumatoid Arthritis Research and Therapies
- Heart Failure Treatment and Management
- Rheumatoid Arthritis Research and Therapies
- HIV/AIDS drug development and treatment
- Atrial Fibrillation Management and Outcomes
- HIV/AIDS drug development and treatment
- Atrial Fibrillation Management and Outcomes
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Allergic Rhinitis and Sensitization
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer Immunotherapy and Biomarkers
- Treatment of Major Depression
- Respiratory and Cough-Related Research
- Respiratory and Cough-Related Research
- Treatment of Major Depression
- Allergic Rhinitis and Sensitization
- Cancer Immunotherapy and Biomarkers
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Opioid Use Disorder Treatment
- Diabetes Management and Research
- Opioid Use Disorder Treatment
- Metabolism, Diabetes, and Cancer
- Autoimmune Bullous Skin Diseases
- Urticaria and Related Conditions
- Metabolism, Diabetes, and Cancer
- Pain Management and Opioid Use
- Autoimmune Bullous Skin Diseases
- Urticaria and Related Conditions
- Pain Management and Opioid Use
Keywords (DOAJ)
- pharmacotherapy
- real-world medicine
- disease management
- drugs
- health economics
- health outcomes
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ